Byron Robinson
Chief Strategy Officer, Janux Therapeutics, Inc.
Companies
- Janux Therapeutics, Inc.Chief Strategy Officer Mar 3, 2022 to Jan 3, 20251
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Janux Therapeutics, Inc. JANX28,000 shares2$485.0K at $17.32Jan 2, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2025Granted 28,000 shares of Janux Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2